New Psychoactive Drugs

Authors

  • Helen Dolengevich-Segal Servicio de Psiquiatría. Hospital Universitario del Henares. Coslada (Madrid)
  • Beatriz Rodríguez Salgado Hospital Ramón y Cajal. Centro de Salud Mental de San Blas, Madrid
  • Jorge Gómez-Arnau Ramírez Servicio de Psiquiatría. Hospital Universitario del Henares. Coslada (Madrid)
  • Daniel Sánchez-Mateos Hospital La Fe, Valencia

DOI:

https://doi.org/10.20882/adicciones.709

Keywords:

Psychoactive Drugs

Abstract

Letter to the editor

References

Davey, Z., Schifano, F., Corazza, O., Deluca, P. y Psychonaut Web Mapping Group. (2012). e-Psychonauts: conducting research in online drug forum communities. Journal of Mental Health, 21, 386-94.

Delegación del Gobierno para el Plan Nacional sobre Drogas (2015). Encuesta sobre alcohol y drogas en la población general en España (EDADES 2013/2014). Ministerio de Sanidad, Servicios Sociales e Igualdad.

Dolengevich-Segal, H., Rodríguez-Salgado, B., Gómez-Arnau, J., Rabito-Alcón, M. F., y Correas-Lauffer, J. (2014). Psychoactive substance use in the Internet era. Revista de Patología Dual, 1, 3-9.

European Monitoring Centre for Drugs and Drug Addiction (2015). New psychoactive substances in Europe. An update from the EU Early Warning System. Publications Office of the European Union, Luxembourg.

Jünger, E. (1987). Visita a Godenholm. Madrid: Alianza editorial (trabajo original publicado en 1952).

Kersten, B. P. y McLaughlin, M.E. (2015). Toxicology and management of novel psychoactive drugs. Journal of Pharmacy Practice, 28, 50-65. doi: 10.1177/0897190014544

Siddiqi, S., Verney, C., Dargan, P. y Wood, D. M. (2015). Understanding the availability, prevalence of use, desired effects, acute toxicity and dependence potential of the novel opioid MT-45. Clinical Toxicology (Philadelphia), 53, 54-59. doi: 10.3109/15563650.2014.983239.

Szerman, N., Martínez-Raga, J., Peris, L., Roncero, C., Basurte, I., Vega, P. y Casas, M. (2013). Rethinking Dual Disorders/Pathology. Addictive Disorders & Their Treatment, 12, 1-10. doi: 10.1097/ADT.0b013e31826e7b6a.

United Nations Office on Drugs and Crime (2013). The Challenge of New Psychoactive Substances. Disponible en: http://www.unodc.org/documents/scientific/NPS _2013_SMART.pdf

Volkow, N. (2001). Drug abuse and mental illness: progress in understanding comorbidity. American Journal of Psychiatry, 158, 1181–1183.

Wood, D. M., Sedefov, R., Cunningham, A., Dargan, P. I. (2015). Prevalence of use and acute toxicity associated with the use of NBOMe drugs. Clinical Toxicology (Philadelphia), 53, 85-92. doi: 10.3109/15563650.2015.1004179.

Downloads

Published

2015-09-15

Issue

Vol. 27 No. 3 (2015)

Section

Letters to the Editors